Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load

NCT05968846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Systemic Amyloidosis

Interventions

DRUG: Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01)

Sponsor

University of Tennessee Graduate School of Medicine